[24] Despite such a pronounced placebo effect in the present study, patients on tolterodine demonstrated consistently greater improvements in micturition diary variables compared with placebo.

Objective: To evaluate the cost-effectiveness of a new extended-release (XL) formulation of oxybutynin relative to tolterodine immediate release (IR), currently the most prescribed treatment for ...

Kaplan et al. investigated the efficacy and safety of the antimuscarinic tolterodine extended release (ER), the α 1-receptor antagonist tamsulosin, and a combination of both, in men with ...